Avaliação cognitiva e adesão ao tratamento de pacientes atendidos no programa de assistência aos portadores de Alzheimer em Picos - PI

Abstract

Alzheimer's disease (AD), growing condition among the elderly, and that limits the autonomy and independence of these is covered with free dispensation of medicines by the State. for AD. Therefore, this study aimed to evaluate the cognitive performance of AD patients benefit from medication for Assistance Program Holders of Alzheimer's disease (PAPDA) in Picos-PI, as well as verify adherence of users to therapy and characterize the profile of these patients. Cognitive assessment was performed using the Mini Mental State Examination (MMSE), Trail Making Test and Clock Drawing Test (CDT). For statistical analysis we used the chi-square test (Pearson coefficient), considering the significance level at p <0.05. The study included 20 people who were assessed on cognitive tests, adherence to treatment (MAT), through home visits. The sample with respect to socioeconomic status were 60% (n = 12) were female and 40% (n = 8) were male, and 70% (n = 14) of these were married. Also, there were the following average schooling found: approximately 7 ± 4.48 years of study and age 76 ± 7.89 years. All survey participants reported that to renew PAPDA made use of private consultation to specialized medical care. Regarding cognitive assessment measured by the MMSE, 40% (n = 8) had scores between 17 and 24 points, 30% (n = 6) had scores from 9 to 16 points, 20% (n = 4) had scores between 1 8 points and 10% (n = 2) had scores between 25 to 30 points verifying statistical difference between MMSE and age (p = 0.04), and significant clue to MMSE and education (p = 0.053). The tracks test was not completed by any of the participants. TDR showed that 30% (n = 6) did not try or failed to understand the request and 35% (n = 7) understood the request and made circles with numbers not connected. The MMSE and TDR correlated (p = 0.038), with a decrease in MMSE scores found in accordance with the increase of TDR score. Evaluation of adherence measure to treatment (MAT) was answered by caregivers and found that all patients adhere to therapy. From the analyzes, it is worth highlighting the use of benzodiazepines for some seniors. There was no significant difference between MMSE and the start of treatment, even with used cholinesterase inhibitors. It is concluded that patients with AD have cognitive decline with severe attention deficit disorder, motor coordination and reduced visual field and good adherence to treatment, but the rational use of anticolisterasicos seems to have no direct association with disease progression and or start time treatment.